EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genetically determined very low lipoprotein(a) is not associated with type 2 diabetes and glycemic traits

Moa P Lee, Paulina Baca, Fernando Rivas, Alice Zhang, Jesus Alegre-Diaz, Jaime Berumen, Pablo Kuri-Morales, Kari E North, Carlos J Rodriguez, Til Stürmer, Ron C Hoogeveen, Christie M Ballantyne und 2 weitere

American Journal of Preventive Cardiology · 2027-01 · 31 · 101716

DOI: 10.1016/j.ajpc.2026.101716 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Preventive Cardiology, 2027-01. Verfasst von Moa P Lee und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NHGRI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lipoprotein (a) [Lp(a)] is an independent atherosclerotic cardiovascular disease risk factor, with levels largely determined by variation in the LPA gene. Despite interests in therapeutic Lp(a) lowering, the phenotypic effects of very low Lp(a) are incompletely characterized, with some studies suggesting increased type 2 diabetes risk.

Objectives

Estimate associations between very low Lp(a), inferred by LPA loss of function variant rs41272114, with type 2 diabetes and glycemic biomarkers.

Methods

A multi-population study of European, Hispanic/Latino, and South Asian populations from five cohort studies was assembled. Effects of the null allele rs41272114 (CC, wild-type; T, null allele) on type 2 diabetes and glycemic biomarkers (fasting glucose, fasting insulin, glycosylated hemoglobin (HbA1c), triglyceride-to-high-density lipoprotein ratio, and HOMA-IR) were estimated using multivariable-adjusted and cohort-specific linear or logistic regression models that were combined using inverse variance meta-analysis.

Results

Of n=519,892 participants, the T null allele was common (n=49,841 CT and n=2,039 TT) and n=38,320 participants had type 2 diabetes (prevalence range: 4.7, 29.5%). Participants with the TT genotype had a median Lp(a) ranging 1.5-1.9 nmol/L compared to median Lp(a) ranging 15.8-30.0 nmol/L in participants with the CC genotype. We did not observe increased odds of type 2 diabetes by rs412722114 genotype (ORCTvs.CC = 0.97, 95% CI: 0.94, 1.00; ORTTvs.CC = 1.01, 95% CI: 0.89, 1.15). Mean levels of glycemic biomarkers also did not differ by rs41272114 genotype.

Conclusions

In a large multi-population study with high burdens of type 2 diabetes, life-long very low Lp(a) did not increase type 2 diabetes risk.

Schlagwörter

Stichwörter der Autor:innen

Glycemic traitsLPA null alleleLipoprotein (a)Low Lp(a)Rs41272114Type 2 diabetes

Autor:innen und Institutionen

  • Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.
  • Unidad de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), CDMX, Mexico.
  • Programa OriGen, Instituto Tecnológico de Monterrey, Monterrey, Nuevo León, Mexico.
  • Department of Medicine (Cardiology), Albert Einstein College of Medicine, New York, NY, USA.
  • Department of Medicine, Texas Heart Institute at Baylor College of Medicine, Houston, TX, USA.
  • Carolina Population Center, University of North Carolina, Chapel Hill, NC, USA.

Förderung

  • NHLBI NIH HHS
  • NHGRI NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Heart Lung and Blood Institute Division of Intramural Research
  • Amgen
  • National Institutes of Health

Zitieren

APA

Lee, M. P., Baca, P., Rivas, F., Zhang, A., Alegre-Diaz, J., Berumen, J., Kuri-Morales, P., North, K. E., Rodriguez, C. J., Stürmer, T., Hoogeveen, R. C., Ballantyne, C. M., Graff, M., & Avery, C. L. (2027). Genetically determined very low lipoprotein(a) is not associated with type 2 diabetes and glycemic traits. American Journal of Preventive Cardiology, 31, 101716. https://doi.org/10.1016/j.ajpc.2026.101716

Vancouver

Lee MP, Baca P, Rivas F, Zhang A, Alegre-Diaz J, Berumen J, et al. Genetically determined very low lipoprotein(a) is not associated with type 2 diabetes and glycemic traits. American Journal of Preventive Cardiology. 2027;31:101716. doi:10.1016/j.ajpc.2026.101716

BibTeX
@article{Lee2027,
  author = {Lee, Moa P and Baca, Paulina and Rivas, Fernando and Zhang, Alice and Alegre-Diaz, Jesus and Berumen, Jaime and Kuri-Morales, Pablo and North, Kari E and Rodriguez, Carlos J and Stürmer, Til and Hoogeveen, Ron C and Ballantyne, Christie M and Graff, Mariaelisa and Avery, Christy L},
  title = {Genetically determined very low lipoprotein(a) is not associated with type 2 diabetes and glycemic traits},
  journal = {American Journal of Preventive Cardiology},
  year = {2027},
  volume = {31},
  pages = {101716},
  doi = {10.1016/j.ajpc.2026.101716}
}
Kostenlos starten →